Vision Point Advisory Group, LLC Pfizer Inc Transaction History

Vision Point Advisory Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$25.26 - $29.6 $2,046 - $2,397	-81 Reduced 96.43%	3 $0
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $25,215 - $32,752	-965 Reduced 91.99%	84 $2,000
Q3 2023 Dec 06, 2023	BUY	$32.09 - $37.51 $33,598 - $39,272	1,047 Added 52350.0%	1,049 $34,000
Q2 2023 Aug 21, 2023	BUY	$36.12 - $41.79 $72 - $83	2 New	2 $0
Q2 2021 Aug 10, 2021	SELL	$35.91 - $40.68 $413,180 - $468,064	-11,506 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $363,165 - $409,577	-10,844 Reduced 48.52%	11,506 $417,000
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $3.29 Million - $4.18 Million	-98,265 Reduced 81.47%	22,350 $823,000
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $1.04 Million - $1.23 Million	-32,897 Reduced 21.43%	120,615 $4.43 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $10,120 - $12,277	336 Added 0.22%	153,512 $5.78 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $4.14 Million - $5.92 Million	153,176 New	153,176 $5 Million

3,271

3.63B

74.3M

107M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Vision Point Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Vision Point Advisory Group, LLC with notifications on news.